{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:18:41Z","timestamp":1789600721853,"version":"build-2803163510"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23AA028297"],"award-info":[{"award-number":["K23AA028297"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The era of biologics is associated with declining rates of surgery for Crohn\u2019s disease (CD), but the impact on surgery for stricturing CD is unknown. Our study aimed to assess nationwide trends in bowel resection surgery for obstruction in CD since the introduction of infliximab for CD in 1998.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using the Nationwide Inpatient Sample, we performed a nationwide analysis, identifying patients hospitalized for CD who underwent bowel resection for an indication of obstruction between 1998 and 2020 (era of biologics). Longitudinal trends in all CD-related resections and resection for obstruction were evaluated. Multivariable logistic regression identified patient and hospital characteristics associated with bowel resection surgery for obstruction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Hospitalizations for all CD-related resections decreased from 12.0% of all hospitalizations in 1998 to 6.9% in 2020, while hospitalizations for CD-related resection for obstructive indication increased from 1.3% to 2.0%. The proportion of resections for obstructive indication amongst all CD-related bowel resections increased from 10.8% in 1998 to 29.1% in 2020. In the multivariable models stratified by elective admission, the increasing year was associated with risk of resection for obstructive indication regardless of urgency (nonelective model: odds ratio, 1.01; 95% CI, 1.00-1.02; elective model: odds ratio, 1.06; 95% CI, 1.04-1.08).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In the era of biologics, our findings demonstrate a decreasing annual rate of CD-related bowel resections but an increase in resection for obstructive indication. Our findings highlight the effect of medical therapy on surgical rates overall but suggest limited impact of current medical therapy on need of resection for stricturing disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izae113","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T13:36:16Z","timestamp":1716644176000},"page":"935-943","source":"Crossref","is-referenced-by-count":15,"title":["Increasing Rates of Bowel Resection Surgery for Stricturing Crohn\u2019s Disease in the Biologic Era"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2019-8002","authenticated-orcid":false,"given":"Kush","family":"Fansiwala","sequence":"first","affiliation":[{"name":"Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA , Los Angeles, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen J","family":"Spartz","sequence":"additional","affiliation":[{"name":"Department of Surgery, David Geffen School of Medicine at UCLA , Los Angeles, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R","family":"Roney","sequence":"additional","affiliation":[{"name":"Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA , Los Angeles, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary R","family":"Kwaan","sequence":"additional","affiliation":[{"name":"Department of Surgery, David Geffen School of Medicine at UCLA , Los Angeles, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny S","family":"Sauk","sequence":"additional","affiliation":[{"name":"Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA , Los Angeles, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9865-1009","authenticated-orcid":false,"given":"Po-Hung","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berkeley N","family":"Limketkai","sequence":"additional","affiliation":[{"name":"Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA , Los Angeles, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"issue":"2","key":"2025041105233948100_CIT0001","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.gtc.2012.01.014","article-title":"Endoscopic assessment of inflammatory bowel disease: colonoscopy\/esophagogastroduodenoscopy","volume":"41","author":"Chan","year":"2012","journal-title":"Gastroenterol Clin North Am."},{"issue":"12","key":"2025041105233948100_CIT0002","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/apt.15750","article-title":"Systematic review: medical therapy for fibrostenosing Crohn\u2019s disease","volume":"51","author":"Lu","year":"2020","journal-title":"Aliment Pharmacol Ther."},{"issue":"8","key":"2025041105233948100_CIT0003","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/apt.13363","article-title":"Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn\u2019s disease","volume":"42","author":"Safroneeva","year":"2015","journal-title":"Aliment Pharmacol Ther."},{"issue":"3","key":"2025041105233948100_CIT0004","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41575-021-00543-0","article-title":"Revisiting fibrosis in inflammatory bowel disease: the gut thickens","volume":"19","author":"D\u2019Alessio","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"7","key":"2025041105233948100_CIT0005","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/ibd.21160","article-title":"Outcome of medical treatment of stricturing and penetrating Crohn\u2019s disease: a retrospective study","volume":"16","author":"Samimi","year":"2010","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"2025041105233948100_CIT0006","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/ajg.2017.394","article-title":"Surgical rates for Crohn\u2019s disease are decreasing: a population-based time trend analysis and validation study","volume":"112","author":"Ma","year":"2017","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"2025041105233948100_CIT0007","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11605-020-04832-y","article-title":"Declining rates of surgery for inflammatory bowel disease in the era of biologic therapy","volume":"25","author":"Lowe","year":"2021","journal-title":"J Gastrointest Surg."},{"issue":"5","key":"2025041105233948100_CIT0008","doi-asserted-by":"publisher","first-page":"e974","DOI":"10.1016\/j.cgh.2020.10.008","article-title":"Rates of intestinal resection and colectomy in inflammatory bowel disease patients after initiation of biologics: a cohort study","volume":"20","author":"Khoudari","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2025041105233948100_CIT0009","volume-title":"HCUP Databases","author":"Healthcare Cost and Utilization Project (HCUP)","year":"2023"},{"issue":"11","key":"2025041105233948100_CIT0010","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol."},{"issue":"5","key":"2025041105233948100_CIT0011","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/MLR.0000000000000905","article-title":"Validation of the combined comorbidity index of Charlson and elixhauser to predict 30-day mortality across ICD-9 and ICD-10","volume":"56","author":"Simard","year":"2018","journal-title":"Med Care."},{"issue":"12","key":"2025041105233948100_CIT0012","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","article-title":"New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality","volume":"57","author":"Sundararajan","year":"2004","journal-title":"J Clin Epidemiol."},{"issue":"15","key":"2025041105233948100_CIT0013","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. Crohn\u2019s Disease cA2 Study Group","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med."},{"issue":"9317","key":"2025041105233948100_CIT0014","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet."},{"issue":"5","key":"2025041105233948100_CIT0015","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/s0016-5085(99)70005-3","article-title":"Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn\u2019s disease: a European multicenter trial","volume":"116","author":"D\u2019Haens","year":"1999","journal-title":"Gastroenterology."},{"issue":"7","key":"2025041105233948100_CIT0016","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1053\/j.gastro.2021.04.022","article-title":"AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn\u2019s disease","volume":"160","author":"Feuerstein","year":"2021","journal-title":"Gastroenterology."},{"issue":"1","key":"2025041105233948100_CIT0017","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/gutjnl-2016-312581","article-title":"Efficacy of adalimumab in patients with Crohn\u2019s disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study","volume":"67","author":"Bouhnik","year":"2018","journal-title":"Gut."},{"issue":"3","key":"2025041105233948100_CIT0018","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/cells11030429","article-title":"Therapeutic targeting of intestinal fibrosis in Crohn\u2019s disease","volume":"11","author":"Santacroce","year":"2022","journal-title":"Cells"},{"issue":"2","key":"2025041105233948100_CIT0019","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00384-020-03786-6","article-title":"A systemic review and metaanalysis of postoperative outcomes in urgent and elective bowel resection in patients with Crohn\u2019s disease","volume":"36","author":"Udholm","year":"2021","journal-title":"Int J Colorectal Dis."},{"issue":"1","key":"2025041105233948100_CIT0020","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MIB.0000000000000988","article-title":"A pooled analysis of efficacy, safety, and long-term outcome of endoscopic balloon dilation therapy for patients with stricturing Crohn\u2019s disease","volume":"23","author":"Bettenworth","year":"2017","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2025041105233948100_CIT0021","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5217\/ir.2019.09158","article-title":"Update of endoscopic management of Crohn\u2019s disease strictures","volume":"18","author":"Pokala","year":"2020","journal-title":"Intest Res"},{"issue":"11","key":"2025041105233948100_CIT0022","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ibd.20200","article-title":"Race and health insurance are predictors of hospitalized Crohn\u2019s disease patients undergoing bowel resection","volume":"13","author":"Nguyen","year":"2007","journal-title":"Inflamm Bowel Dis."},{"issue":"6","key":"2025041105233948100_CIT0023","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.crohns.2011.06.002","article-title":"Prediction of disease complication occurrence in Crohn\u2019s disease using phenotype and genotype parameters at diagnosis","volume":"5","author":"Mazor","year":"2011","journal-title":"J Crohns Colitis."},{"issue":"6","key":"2025041105233948100_CIT0024","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/ibd\/izy004","article-title":"Sex-related differences in patients with inflammatory bowel disease: results of 2 prospective cohort studies","volume":"24","author":"Severs","year":"2018","journal-title":"Inflamm Bowel Dis."},{"issue":"11","key":"2025041105233948100_CIT0025","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/ajg.2012.298","article-title":"Surgery in a population-based cohort of Crohn\u2019s disease from Olmsted County, Minnesota (1970-2004)","volume":"107","author":"Peyrin-Biroulet","year":"2012","journal-title":"Am J Gastroenterol."},{"issue":"7","key":"2025041105233948100_CIT0026","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/healthcare9070805","article-title":"Post-operative all-cause mortality in elderly patients undergoing abdominal emergency surgery: role of Charlson Comorbidity Index","volume":"9","author":"Fabbian","year":"2021","journal-title":"Healthcare"},{"issue":"4","key":"2025041105233948100_CIT0027","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-0041-1729926","article-title":"Crohn\u2019s disease obstructions","volume":"34","author":"Ford","year":"2021","journal-title":"Clin Colon Rectal Surg"},{"issue":"4","key":"2025041105233948100_CIT0028","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/00365521.2020.1740778","article-title":"The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register","volume":"55","author":"Shrestha","year":"2020","journal-title":"Scand J Gastroenterol."},{"key":"2025041105233948100_CIT0029","doi-asserted-by":"crossref","first-page":"102173","DOI":"10.1016\/j.pmedr.2023.102173","article-title":"Inflammatory bowel disease prevalence: surveillance data from the U.S. National Health and Nutrition Examination Survey","volume":"33","author":"Weisman","year":"2023","journal-title":"Prev Med Rep"},{"issue":"42","key":"2025041105233948100_CIT0030","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.15585\/mmwr.mm6542a3","article-title":"Prevalence of inflammatory bowel disease among adults aged &gt;\/=18 years - United States, 2015","volume":"65","author":"Dahlhamer","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izae113\/57907102\/izae113.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/4\/935\/57907102\/izae113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/4\/935\/57907102\/izae113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T05:23:52Z","timestamp":1744349032000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/4\/935\/7682233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5,25]]},"published-print":{"date-parts":[[2025,4,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izae113","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,5,25]]}}}